UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1137-1149

1994

Volltextzugriff (PDF)

Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets

PloS one, 2008-08, Vol.3 (8), p.e2994-e2994

2008

Volltextzugriff (PDF)

Breast Tumor Characterization Using [ 18 F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics

Cancers, 2021-03, Vol.13 (6), p.1249

2021

Volltextzugriff (PDF)

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901

Journal of clinical oncology, 2014-08, Vol.32 (23), p.2416-2422

2014

Volltextzugriff (PDF)

EORTC phase II trial of vindesine in advanced melanoma

European journal of cancer & clinical oncology, 1983-01, Vol.19 (8), p.1173-1174

1983

Volltextzugriff (PDF)

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

The New England journal of medicine, 2018-06, Vol.378 (24), p.2288-2301

2018

Volltextzugriff (PDF)

IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

Journal of thoracic oncology, 2021-11, Vol.16 (11), p.1909-1924

2021

Volltextzugriff (PDF)

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

The lancet oncology, 2017-09, Vol.18 (9), p.1159-1171

2017

Volltextzugriff (PDF)

Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia

Cancer cell, 2017-10, Vol.32 (4), p.490-505.e10

2017

Volltextzugriff (PDF)

A Case Study in Proton Pencil-Beam Scanning Delivery

International journal of radiation oncology, biology, physics, 2010-02, Vol.76 (2), p.624-630

2010

Volltextzugriff (PDF)

Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial

The lancet oncology, 2020-12, Vol.21 (12), p.1563-1573

2020

Volltextzugriff (PDF)

CD74-NRG1 fusions in lung adenocarcinoma

Cancer discovery, 2014-04, Vol.4 (4), p.415-422

2014

Volltextzugriff (PDF)

Azacitidine for the treatment of relapsed and refractory AML in older patients

Leukemia research, 2015-02, Vol.39 (2), p.124-130

2015

Volltextzugriff (PDF)

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

Journal of clinical oncology, 2009-12, Vol.27 (34), p.5700-5706

2009

Volltextzugriff (PDF)

Genomic Characterization of Primary Invasive Lobular Breast Cancer

Journal of clinical oncology, 2016-06, Vol.34 (16), p.1872-1881

2016

Volltextzugriff (PDF)

IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain

Journal of thoracic oncology, 2022-02, Vol.17 (2), p.309-323

2022

Volltextzugriff (PDF)

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity

Journal of clinical oncology, 2014-12, Vol.32 (34), p.3858-3867

2014

Volltextzugriff (PDF)

Lung Cancer in France

Journal of thoracic oncology, 2021-01, Vol.16 (1), p.21-29

2021

Volltextzugriff (PDF)

Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: A 20‐year experience

Cancer, 2022-11, Vol.128 (21), p.3824-3830

2022

Volltextzugriff (PDF)

Imaging biomarker roadmap for cancer studies

Nature reviews. Clinical oncology, 2017-03, Vol.14 (3), p.169-186

2017

Volltextzugriff (PDF)

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial

Journal of clinical oncology, 2021-10, Vol.39 (29), p.3242-3250

2021

Volltextzugriff (PDF)

A Concise Paradigm on Radical Hysterectomy: The Comprehensive Anatomy of Parametrium, Paracolpium and the Pelvic Autonomic Nerve System and Its Surgical Implication

Cancers, 2020-07, Vol.12 (7), p.1839

2020

Volltextzugriff (PDF)

Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study

Clinical cancer research, 2018-11, Vol.24 (21), p.5219-5224

2018

Volltextzugriff (PDF)

Is Hepatic Resection Justified After Chemotherapy in Patients With Colorectal Liver Metastases and Lymph Node Involvement?

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3672-3680

2008

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(211)

Publikationsform

Artikel
(230)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(229)
Life Sciences & Biomedicine
(224)
Humans
(162)
Female
(100)
Male
(94)
Middle Aged
(84)
Aged
(70)
Cancer
(65)
Adult
(64)
Life Sciences
(62)
Tumors
(52)
Chemotherapy
(46)
Prognosis
(45)
Patients
(43)
Biological And Medical Sciences
(40)
Medical Sciences
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(38)
Hematology
(38)
Treatment Outcome
(32)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets

Breast Tumor Characterization Using [ 18 F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901

EORTC phase II trial of vindesine in advanced melanoma

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia

A Case Study in Proton Pencil-Beam Scanning Delivery

Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial

CD74-NRG1 fusions in lung adenocarcinoma

Azacitidine for the treatment of relapsed and refractory AML in older patients

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

Genomic Characterization of Primary Invasive Lobular Breast Cancer

IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity

Lung Cancer in France

Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: A 20‐year experience

Imaging biomarker roadmap for cancer studies

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial

A Concise Paradigm on Radical Hysterectomy: The Comprehensive Anatomy of Parametrium, Paracolpium and the Pelvic Autonomic Nerve System and Its Surgical Implication

Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study

Is Hepatic Resection Justified After Chemotherapy in Patients With Colorectal Liver Metastases and Lymph Node Involvement?

Aktive Filter

Suchergebnisse filtern